GIMM researchers have recently been awarded a series of highly competitive international grants, reinforcing the institute’s strong position across diverse areas of biomedical and fundamental research.

Ana Maceiras, from Luís Graça lab, has been awarded an ERA Marie Skłodowska-Curie Postdoctoral Fellowship 2025. Her project addresses a key challenge in public health: why vaccination against influenza does not elicit the same level of protection in all individuals. Focusing on a cohort of people over 70 years old, Ana will use single-cell technologies to identify which immune cells respond to the vaccine and try to understand the differences underlying variable immune responses.

Rafael Blanco Domínguez, from the Ribot and Silva-Santos Lab, has received the 2026 EACR–Mark Foundation Postdoctoral Fellowship. This three-year position will support his project “Decoding Delta One T Cell adaptation and regulation in colorectal cancer for improved immunotherapy”, advancing research into immune mechanisms with potential clinical impact in cancer treatment.

Moisés Mallo has been awarded a Human Frontier Science Program Research Grant 2026 for the project “How snakes lost their limbs”. This three-year grant, starting in September 2026, will explore the genetic and developmental mechanisms behind limb loss in snakes and other elongated vertebrates. By combining genomics and experimental approaches, the project aims to shed light on one of the most intriguing questions in evolutionary biology.

Carmo Fonseca is a partner in the Doctoral Networks 2025 funded project DECODES, coordinated by the Universidad de Santiago de Compostela. The project will fund one PhD student at GIMM for three years under her supervision, with a total budget allocation of €279,445.32 to the institute. This call was highly competitive, with only 141 programs funded out of 1,616 applications (8.7% success rate). GIMM achieved a success rate of 9%.

These achievements highlight the breadth and excellence of research at GIMM, spanning immunology, cancer, and evolutionary biology, and reflect continued success in securing prestigious and competitive funding.

Ana Maceiras
Luís Graça Lab

Rafael Blanco Domínguez
Ribot and Silva-Santos Lab

Moisés Mallo
CSO and Group Leader

M. Carmo-Fonseca
Group Leader